Grosmaire; Laura S.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Grosmaire; Laura S..The latest application filed is for "b-cell reduction using cd37-specific and cd20-specific binding molecules".
- Grosmaire; Laura S. - Hobart WA US
| Patent | Date |
|---|---|
| CD37 immunotherapeutics and uses thereof Grant 10,307,481 - Grosmaire , et al. | 2019-06-04 |
| B-cell Reduction Using Cd37-specific And Cd20-specific Binding Molecules App 20090214539 - Grosmaire; Laura S. ; et al. | 2009-08-27 |
| B-cell reduction using CD37-specific and CD20-specific binding molecules App 20070059306 - Grosmaire; Laura S. ; et al. | 2007-03-15 |
| Compositions and methods for regulating lymphocyte activation App 20050261478 - Ledbetter, Jeffrey A. ; et al. | 2005-11-24 |
| Compositions and methods for regulating lymphocyte activation App 20040253250 - Ledbetter, Jeffrey A. ; et al. | 2004-12-16 |
| Compositions And Methods For Regulating Lymphocyte Activation App 20020155604 - LEDBETTER, JEFFREY A. ; et al. | 2002-10-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 